← Back
Data updated: Mar 10, 2026
ALPHARMA
OncologyInfectious DiseaseCardiovascular
ALPHARMA is a pharmaceutical company focused on Oncology, Infectious Disease, Cardiovascular.
-
Since
1
Drugs
-
Trials
39
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
HALOPERIDOL 2025-12-18
HALOPERIDOL 2025-02-26
Labeling
HALOPERIDOL 2025-01-22
Labeling
HALOPERIDOL 2025-01-22
Labeling
HALOPERIDOL 2025-01-22
Labeling
HALOPERIDOL 2025-01-22
Labeling
HALOPERIDOL 2025-01-22
Labeling
HALOPERIDOL 2025-01-22
Labeling
HALOPERIDOL 2025-01-22
Labeling
HALOPERIDOL 2025-01-22
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 51%
0 drugs Phase 3: 2 Phase 2: 8 Phase 1: 14
Infectious Disease 22%
0 drugs Phase 3: 2 Phase 2: 3 Phase 1: 2
Cardiovascular 11%
0 drugs Phase 3: 1 Phase 2: 1 Phase 1: 2
Neurology 9%
0 drugs Phase 2: 3 Phase 1: 1
Ophthalmology 7%
0 drugs Phase 3: 1 Phase 1: 1
Pipeline Strength Pro
Loading...
Competitors Pro
Baxter specialty
Infectious Disease, Cardiovascular, Oncology, Ophthalmology
AbbVie big-pharma
Oncology, Neurology, Infectious Disease, Ophthalmology
Novartis big-pharma
Oncology, Cardiovascular, Ophthalmology
GE HEALTHCARE specialty
Infectious Disease, Neurology, Cardiovascular, Oncology
FOUGERA PHARMS other
Ophthalmology, Infectious Disease, Oncology, Cardiovascular